{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:35:38Z","timestamp":1791041738114,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/31\/B\/NZ5\/01556"],"award-info":[{"award-number":["2018\/31\/B\/NZ5\/01556"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/31\/B\/NZ5\/01556"],"award-info":[{"award-number":["2018\/31\/B\/NZ5\/01556"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/31\/B\/NZ5\/01556"],"award-info":[{"award-number":["2018\/31\/B\/NZ5\/01556"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The development of coronary artery disease (CAD) is the result of complex interactions between environmental and genetic factors. While the former is well known, the genetic factors that predispose individuals to the development of CAD are still under investigation. The aim of our study was to investigate whether single nucleotide polymorphisms (SNPs) in the gene encoding the receptor for advanced glycation end products (\n                      <jats:italic>RAGE<\/jats:italic>\n                      ), specifically rs2070600 G\/A and rs184003 G\/T, may determine predisposition to acute coronary syndrome (ACS) and severity of coronary artery disease (CAD) in the Polish population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Two\n                      <jats:italic>RAGE<\/jats:italic>\n                      SNPs were genotyped in 336 patients with a history of acute coronary syndrome (ACS): 175\u2009&lt;\u200950 years, 161\u2009\u2265\u200950 years, and 160 ethnically, age- and sex-matched controls via the restriction fragment length polymorphism method. Allele frequencies were compared between groups via the chi\n                      <jats:sup>2<\/jats:sup>\n                      test on a 2\u2009\u00d7\u20092 contingency table. Genotype distribution was analyzed assuming three modes of inheritance: dominant, codominant, or recessive. The values of the variables between the study groups were compared using Student\u2019s t-test or the Mann-Whitney\n                      <jats:italic>U<\/jats:italic>\n                      test, as appropriate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      For the rs184003 G\/T polymorphism, the frequency of genotypes containing the T allele (GT\u2009+\u2009TT) was significantly greater in patients with a history of ACS than in healthy age- and sex-matched controls (28.87% vs. 11.25%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001, OR\u2009=\u20093.2 [95% CI: 1.86\u20135.52]). Moreover, individuals possessing this allele had lower high-density lipoprotein (HDL) cholesterol levels (mean 1.02 mmol\/l vs. 1.14 mmol\/l,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01) and higher median troponin I concentrations at the time of ACS (32.2 ng\/ml vs. 24.4 ng\/ml,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04). These genotypes were also significantly less common in patients with ACS before the age of 50 than in those diagnosed later (20.0% vs. 38.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0002, OR\u2009=\u20090.4 [95%CI: 0.25\u20130.65]). In the case of rs2070600 G\/A polymorphism, the genotype and allele frequencies were not significantly different between the study groups and subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our findings suggest that the rs184003 SNP in the\n                      <jats:italic>RAGE<\/jats:italic>\n                      gene may play a role in determining genetic susceptibility to CAD and ACS in the Polish population. However, they do not support the hypothesis that the studied SNPs impact the incidence of ACS at a young age.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-025-02215-3","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:03:19Z","timestamp":1759230199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advanced glycation end-product receptor gene (RAGE) polymorphisms in patients with acute coronary syndrome \u2013 a case-control study in the Polish population"],"prefix":"10.1186","volume":"18","author":[{"given":"Klaudia","family":"Gutowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Ambroziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Podraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Puzianowska-Ku\u017anicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Czajkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Budaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8632-4927","authenticated-orcid":false,"given":"Alina","family":"Kury\u0142owicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"2215_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07132-x","volume":"9","author":"Q Yang","year":"2018","unstructured":"Yang Q, Xu J, Ma Q, Liu Z, Sudhahar V, Cao Y, et al. PRKAA1\/AMPK\u03b11-driven glycolysis in endothelial cells exposed to disturbed flow protects against atherosclerosis. Nat Commun. 2018;9: 4667. https:\/\/doi.org\/10.1038\/s41467-018-07132-x.","journal-title":"Nat Commun"},{"key":"2215_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/cvr\/cvx226","volume":"114","author":"S Mundi","year":"2018","unstructured":"Mundi S, Massaro M, Scoditti E, Carluccio MA, van Hinsbergh VWM, Iruela-Arispe ML. Endothelial permeability, LDL deposition, and cardiovascular risk factors\u2014a review. Cardiovasc Res. 2018;114:35\u201352. https:\/\/doi.org\/10.1093\/cvr\/cvx226.","journal-title":"Cardiovasc Res"},{"key":"2215_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s42255-021-00425-4","volume":"3","author":"SM Lam","year":"2021","unstructured":"Lam SM, Zhang C, Wang Z, Ni Z, Zhang S, Yang S, et al. A multiomics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat Metab. 2021;3:909\u201322. https:\/\/doi.org\/10.1038\/s42255-021-00425-4.","journal-title":"Nat Metab"},{"key":"2215_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5: 56. https:\/\/doi.org\/10.1038\/s41572-019-0106-z.","journal-title":"Nat Rev Dis Primers"},{"key":"2215_CR5","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","volume":"129","author":"AS Go","year":"2014","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics\u20142014 update: a report from the American Heart Association. Circulation. 2014;129:e28-292. https:\/\/doi.org\/10.1161\/01.cir.0000441139.02102.80.","journal-title":"Circulation"},{"key":"2215_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","volume":"400","author":"GBD 2019 Cancer Risk Factors Collaborators","year":"2019","unstructured":"GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the global burden of disease study 2019. Lancet. 2019;400:563\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(22)01438-6.","journal-title":"Lancet"},{"key":"2215_CR7","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2337\/diabetes.53.7.1813","volume":"53","author":"JM Forbes","year":"2004","unstructured":"Forbes JM, Yee LT, Thallas V, Lassila M, Candido R, Jandeleit-Dahm KA, et al. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes. 2004;53:1813\u201323. https:\/\/doi.org\/10.2337\/diabetes.53.7.1813.","journal-title":"Diabetes"},{"key":"2215_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s001250051591","volume":"44","author":"R Singh","year":"2001","unstructured":"Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:129\u201346. https:\/\/doi.org\/10.1007\/s001250051591.","journal-title":"Diabetologia"},{"key":"2215_CR9","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3390\/nu2121247","volume":"2","author":"C Luevano-Contreras","year":"2010","unstructured":"Luevano-Contreras C, Chapman-Novakofski K. Dietary advanced glycation end products and aging. Nutrients. 2010;2:1247\u201365. https:\/\/doi.org\/10.3390\/nu2121247.","journal-title":"Nutrients"},{"key":"2215_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2023.114337","volume":"271","author":"KD Carr","year":"2023","unstructured":"Carr KD, Weiner SP, Vasquez C, Schmidt AM. Involvement of the receptor for advanced glycation end products (RAGE) in high fat-high sugar diet-induced anhedonia in rats. Physiol Behav. 2023;271: 114337. https:\/\/doi.org\/10.1016\/j.physbeh.2023.114337.","journal-title":"Physiol Behav"},{"key":"2215_CR11","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2174\/1381612822666161006143032","volume":"23","author":"K Prasad","year":"2017","unstructured":"Prasad K, Tiwari ST. Interventions for advanced Glycation-End products and its Receptor-Mediated cardiovascular disease. Curr Pharm Des. 2017;23:937\u201343. https:\/\/doi.org\/10.2174\/1381612822666161006143032.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"2215_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/gerona\/62.4.427","volume":"62","author":"J Uribarri","year":"2007","unstructured":"Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007;62(4):427\u201333. https:\/\/doi.org\/10.1093\/gerona\/62.4.427.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2215_CR13","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/01.ATV.0000131783.74034.97","volume":"24","author":"AP Burke","year":"2004","unstructured":"Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol. 2004;24:1266\u201371. https:\/\/doi.org\/10.1161\/01.ATV.0000131783.74034.97.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2215_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5387\/fms.2019-12","volume":"65","author":"H Uekita","year":"2016","unstructured":"Uekita H, Ishibashi T, Shiomi M, Koyama H, Ohtsuka S, Yamamoto H, et al. Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis. Fukushima J Med Sci. 2016;65:109\u201321. https:\/\/doi.org\/10.5387\/fms.2019-12.","journal-title":"Fukushima J Med Sci"},{"key":"2215_CR15","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1161\/ATVBAHA.115.305608","volume":"35","author":"A Oesterle","year":"2015","unstructured":"Oesterle A, Bowman MA. S100A12 and the S100\/calgranulins: emerging biomarkers for atherosclerosis and possibly therapeutic targets. Arterioscler Thromb Vasc Biol. 2015;35:2496\u2013507. https:\/\/doi.org\/10.1161\/ATVBAHA.115.305608.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2215_CR16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1161\/ATVBAHA.118.312319","volume":"39","author":"H Grauen Larsen","year":"2019","unstructured":"Grauen Larsen H, Marinkovic G, Nilsson PM, Nilsson J, Engstr\u00f6m G, Melander O, et al. High plasma sRAGE (soluble receptor for advanced glycation end products) is associated with slower carotid intima-media thickness progression and lower risk for first-time coronary events and mortality. Arterioscler Thromb Vasc Biol. 2019;39(5):925\u201333. https:\/\/doi.org\/10.1161\/ATVBAHA.118.312319.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2215_CR17","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.2337\/db11-0291","volume":"60","author":"HM Colhoun","year":"2011","unstructured":"Colhoun HM, Betteridge DJ, Durrington P, Hitman G, Neil A, Livingstone S, et al. Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial. Diabetes. 2011;60:2379\u201385. https:\/\/doi.org\/10.2337\/db11-0291.","journal-title":"Diabetes"},{"key":"2215_CR18","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.2337\/db09-1509","volume":"59","author":"JW Nin","year":"2010","unstructured":"Nin JW, Jorsal A, Ferreira I, Schalkwijk CG, Prins MH, Parving HH, et al. Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes. 2010;59:2027\u201332. https:\/\/doi.org\/10.2337\/db09-1509.","journal-title":"Diabetes"},{"key":"2215_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2015.02.015","volume":"240","author":"BI Hudson","year":"2015","unstructured":"Hudson BI, Gardener H, Liu-Mares W, Dong C, Cheung K, Elkind MS, et al. Serum soluble RAGE levels and carotid atherosclerosis: the Northern Manhattan study (NOMAS). Atherosclerosis. 2015;240:17\u201320. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.02.015.","journal-title":"Atherosclerosis"},{"key":"2215_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.101821","volume":"48","author":"SU Khan","year":"2023","unstructured":"Khan SU, Saeed S, Alsuhaibani AM, Fatima S, Ur Rehman K, Zaman U, et al. Advances and challenges for GWAS analysis in cardiac diseases: a focus on coronary artery disease (CAD). Curr Probl Cardiol. 2023;48: 101821. https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101821.","journal-title":"Curr Probl Cardiol"},{"key":"2215_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.gene.2018.07.048","volume":"677","author":"M Ambroziak","year":"2018","unstructured":"Ambroziak M, Kury\u0142owicz A, Roszkowska-Gancarz M, Budaj A. ESR2 gene G1730A variant is associated with triglycerides level and myocardial infarction in young men but not in women. Gene. 2018;677:83\u20138. https:\/\/doi.org\/10.1016\/j.gene.2018.07.048.","journal-title":"Gene"},{"key":"2215_CR22","first-page":"219","volume":"1","author":"G Sianos","year":"2005","unstructured":"Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1:219\u201327.","journal-title":"EuroIntervention"},{"key":"2215_CR23","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/s0002-8703(05)80173-5","volume":"119","author":"DR Sullivan","year":"1990","unstructured":"Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J. 1990;119:1262\u20137. https:\/\/doi.org\/10.1016\/s0002-8703(05)80173-5.","journal-title":"Am Heart J"},{"key":"2215_CR24","doi-asserted-by":"publisher","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, ESC scientific document group, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339.","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"2215_CR25","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","volume":"45","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45:2753\u201386. https:\/\/doi.org\/10.2337\/dci22-0034.","journal-title":"Diabetes Care"},{"key":"2215_CR26","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215. https:\/\/doi.org\/10.1093\/nar\/16.3.1215.","journal-title":"Nucleic Acids Res"},{"key":"2215_CR27","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.3390\/molecules25235591","volume":"25","author":"CY Shen","year":"2020","unstructured":"Shen CY, Lu CH, Wu CH, Li KJ, Kuo YM, Hsieh SC, et al. The development of Maillard reaction, and advanced glycation end product (AGE)-Receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with AGE-Related diseases. Molecules. 2020;25:5591. https:\/\/doi.org\/10.3390\/molecules25235591.","journal-title":"Molecules"},{"key":"2215_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-014-0026-6","volume":"4","author":"LL Johnson","year":"2014","unstructured":"Johnson LL, Tekabe Y, Kollaros M, Eng G, Bhatia K, Li C, et al. Imaging RAGE expression in atherosclerotic plaques in hyperlipidemic pigs. EJNMMI Res. 2014;4: 26. https:\/\/doi.org\/10.1186\/s13550-014-0026-6.","journal-title":"EJNMMI Res"},{"key":"2215_CR29","doi-asserted-by":"publisher","first-page":"2067353","DOI":"10.1155\/2019\/2067353","volume":"2019","author":"M Serveaux-Dancer","year":"2019","unstructured":"Serveaux-Dancer M, Jabaudon M, Creveaux I, Belville C, Blondonnet R, Gross C, et al. Pathological implications of receptor for advanced glycation End-Product (AGER) gene polymorphism. Dis Markers. 2019;2019:2067353. https:\/\/doi.org\/10.1155\/2019\/2067353.","journal-title":"Dis Markers"},{"key":"2215_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1744-313X.2011.01073.x","volume":"39","author":"MC Torres","year":"2012","unstructured":"Torres MC, Beltrame MH, Santos IC, Picheth G, Petzl-Erler ML, Pedrosa FO, et al. Polymorphisms of the promoter and exon 3 of the receptor for advanced glycation end products (RAGE) in Euro- and Afro-Brazilians. Int J Immunogenet. 2012;39:155\u201360. https:\/\/doi.org\/10.1111\/j.1744-313X.2011.01073.x.","journal-title":"Int J Immunogenet"},{"key":"2215_CR31","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.bbagen.2007.07.003","volume":"1770","author":"M Osawa","year":"2007","unstructured":"Osawa M, Yamamoto Y, Munesue S, Murakami N, Sakurai S, Watanabe T, et al. De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts. Biochim Biophys Acta. 2007;1770:1468\u201374. https:\/\/doi.org\/10.1016\/j.bbagen.2007.07.003.","journal-title":"Biochim Biophys Acta"},{"key":"2215_CR32","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.2337\/db07-1808","volume":"57","author":"A Soro-Paavonen","year":"2008","unstructured":"Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes. 2008;57:2461\u20139. https:\/\/doi.org\/10.2337\/db07-1808.","journal-title":"Diabetes"},{"key":"2215_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/sj.gene.6363861","volume":"3","author":"MA Hofmann","year":"2002","unstructured":"Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 2002;3:123\u201335. https:\/\/doi.org\/10.1038\/sj.gene.6363861.","journal-title":"Genes Immun"},{"key":"2215_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005593","volume":"95","author":"WQ Ma","year":"2016","unstructured":"Ma WQ, Qu QR, Zhao Y, Liu NF. Association of RAGE gene Gly82Ser polymorphism with coronary artery disease and ischemic stroke: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95: e5593. https:\/\/doi.org\/10.1097\/MD.0000000000005593.","journal-title":"Medicine (Baltimore)"},{"key":"2215_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/1479-7364-4-5-284","volume":"4","author":"DN Cooper","year":"2010","unstructured":"Cooper DN. Functional intronic polymorphisms: buried treasure awaiting discovery within our genes. Hum Genomics. 2010;4:284\u20138. https:\/\/doi.org\/10.1186\/1479-7364-4-5-284.","journal-title":"Hum Genomics"},{"key":"2215_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-017-0391-0","volume":"17","author":"T Li","year":"2017","unstructured":"Li T, Qin W, Liu Y, Li S, Qin X, Liu Z. Effect of RAGE gene polymorphisms and circulating sRAGE levels on susceptibility to gastric cancer: a case-control study. Cancer Cell Int. 2017;17: 19. https:\/\/doi.org\/10.1186\/s12935-017-0391-0.","journal-title":"Cancer Cell Int"},{"key":"2215_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.bbrc.2016.09.074","volume":"479","author":"M Miyashita","year":"2016","unstructured":"Miyashita M, Watanabe T, Ichikawa T, Toriumi K, Horiuchi Y, Kobori A, et al. The regulation of soluble receptor for ages contributes to carbonyl stress in schizophrenia. Biochem Biophys Res Commun. 2016;479:447\u201352. https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.074.","journal-title":"Biochem Biophys Res Commun"},{"key":"2215_CR38","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1053\/meta.2001.26757","volume":"50","author":"K Kankov\u00e1","year":"2001","unstructured":"Kankov\u00e1 K, M\u00e1rov\u00e1 I, Z\u00e1hejsk\u00fd J, Muz\u00edk J, Stejskalov\u00e1 A, Znojil V, V\u00e1cha J. Polymorphisms 1704G\/T and 2184A\/G in the RAGE gene are associated with antioxidant status. Metabolism. 2001;50:1152\u201360. https:\/\/doi.org\/10.1053\/meta.2001.26757.","journal-title":"Metabolism"},{"key":"2215_CR39","unstructured":"6-32182519-. C-A | gnomAD v4.1.0 | gnomAD."},{"key":"2215_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076966","volume":"8","author":"X Yu","year":"2013","unstructured":"Yu X, Liu J, Zhu H, Xia Y, Gao L, Li Z, et al. An interactive association of advanced glycation end-product receptor gene four common polymorphisms with coronary artery disease in Northeastern Han Chinese. PLoS One. 2013;8: e76966. https:\/\/doi.org\/10.1371\/journal.pone.0076966.","journal-title":"PLoS One"},{"key":"2215_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng.2480","volume":"45","author":"P Deloukas","year":"2013","unstructured":"Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes T, Thompson J, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25\u201333. https:\/\/doi.org\/10.1038\/ng.2480.","journal-title":"Nat Genet"},{"key":"2215_CR42","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","volume":"47","author":"M Nikpay","year":"2015","unstructured":"Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, et al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47:1121\u201330. https:\/\/doi.org\/10.1038\/ng.3396.","journal-title":"Nat Genet"},{"key":"2215_CR43","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/CIRCRESAHA.115.306566","volume":"118","author":"R McPherson","year":"2016","unstructured":"McPherson R, Tybjaerg-Hansen A. Genetics of coronary artery disease. Circ Res. 2016;118:564\u201378. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306566.","journal-title":"Circ Res"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02215-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02215-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02215-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:03:20Z","timestamp":1759230200000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-025-02215-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2215"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02215-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6519950\/v1","asserted-by":"object"}]},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Center of Postgraduate Medical Education Warsaw, Poland (decision 161\/2015). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}